Xiangbo Meng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Longjun Li, Rudi Mao, Shenli Yuan, Qingqing Xie, Jinyu Meng, Yu Gu, Siyu Tan, Xiaoqing Xu, Chengjiang Gao, Hongbin Liu, Chunhong Ma, Si Ming Man, Xiangbo Meng, Tao Xu, Xiao-Peng Qi
NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance. Nature communications 15 (1) (2024)
Longjun Li, Rudi Mao, Shenli Yuan, Qingqing Xie, Jinyu Meng, Yu Gu, Siyu Tan, Xiaoqing Xu, Chengjiang Gao, Hongbin Liu, Chunhong Ma, Si Ming Man, Xiangbo Meng, Tao Xu, Xiao-Peng Qi
NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance. Nature communications 15 (1) (2024)
Xiwei Liu, Xiangbo Meng, Zuomiao Lin, Shutan Jiang, Haifeng Liu, Shao-Cong Sun, Xiaolong Liu, Penghui Zhou, Xiaowu Huang, Lai Wei, Wei Yang, Chenqi Xu
Cytoplasmic FBXO38 mediates PD-1 degradation. EMBO reports (2024)
Longjun Li, Rudi Mao, Shenli Yuan, Qingqing Xie, Jinyu Meng, Yu Gu, Siyu Tan, Xiaoqing Xu, Chengjiang Gao, Hongbin Liu, Chunhong Ma, Si Ming Man, Xiangbo Meng, Tao Xu, Xiao-Peng Qi
NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance. Nature communications 15 (1) (2024)